(Q37033860)

17 August 2017

1 reference

title

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer (English)

1 reference

17 August 2017

1

Andrew V Schally

1 reference

17 August 2017

Jozsef L Varga

2

1 reference

17 August 2017

Jörg B Engel

series ordinal

3

1 reference

17 August 2017

publication date

1 January 2008

1 reference

Nature Clinical Practice Endocrinology and Metabolism

17 August 2017

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

33-43

1 reference

EFFECT OF HYPOTHALAMIC EXTRACTS ON RELEASE OF GROWTH HORMONE IN VITRO.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Neuroendocrine control of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Insulin-like growth factors: the unrecognised oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Involvement of IGF-II in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of Metastatic Behavior of Murine Osteosarcoma by Hypophysectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of growth hormone-releasing hormone in oncology

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumour growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Plasma GH responses to human GHRH-antagonist in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Blockade of endogenous growth hormone-releasing hormone receptors dissociates nocturnal growth hormone secretion and slow-wave sleep

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

The role of endogenous growth hormone-releasing hormone in acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Identification of the glomerular podocyte as a target for growth hormone action

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0677

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0677

1 reference

17 August 2017

1 reference